glp 1 drug novo nordisk asks FDA to prevent compounders from making GLP-1 knockoffs Novo Nordisk, Hims & Hers

In comparison to inorganic and organic compounds (in which inorganic forms are more harmful than organic ones), SeNPs have gained considerable attention due to their high bioavailability, strong biological activity, and low toxicity

Current recommendations from the American Society for Metabolic and Bariatric Surgery and the Endocrine Society support considering these agents as part of comprehensive management when lifestyle modifications prove insufficient and specific clinical criteria are met

Fredholm BB, Chen J-F, Masino SA, Vaugeois J-M (2005) Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs

Consult a licensed healthcare provider before use